Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Xanomeline oxalate (CAS 141064-23-5)

0.0(0)
Write a reviewAsk a question

Alternate Names:
3-[4-(Hexyloxy)-1,2,5-thiadiazol-3- yl]-1,2,5,6-tetrahydro-1-methylpyridine oxalate
Application:
Xanomeline oxalate is a functionally selective mAChR M1 agonist
CAS Number:
141064-23-5
Purity:
≥98%
Molecular Weight:
371.45
Molecular Formula:
C14H23N3OS•C2H2O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Xanomeline oxalate is a functionally selective mAChR M1 agonist (EC50 values are 0.3, 5, 42, 52 and 92.5 nM at mAChR M1, mAChR M3, mAChR M5, mAChR M4 and mAChR M2 receptors, respectively). It exhibits a reversible and wash-resistant binding resulting in full agonist activity at mAChR M1, delayed wash-resistant partial agonist activity at mAChR M2 and delayed wash-resistant full agonist activity at mAChR M4.


Xanomeline oxalate (CAS 141064-23-5) References

  1. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.  |  Stanhope, KJ., et al. 2001. J Pharmacol Exp Ther. 299: 782-92. PMID: 11602695
  2. Evaluation of [18F]fluoroxanomeline {5-{4-[(6-[18F]fluorohexyl)oxy]-1,2,5-thiadiazol-3-yl}-1-methyl-1,2,3,6-tetrahydropyridine} in muscarinic knockout mice.  |  Kiesewetter, DO., et al. 2007. Nucl Med Biol. 34: 141-52. PMID: 17307122
  3. Importance and prospects for design of selective muscarinic agonists.  |  Jakubík, J., et al. 2008. Physiol Res. 57 Suppl 3: S39-S47. PMID: 18481916
  4. Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists.  |  Heinrich, JN., et al. 2009. Eur J Pharmacol. 605: 53-6. PMID: 19168056
  5. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.  |  Brown, JW., et al. 2014. Prog Neuropsychopharmacol Biol Psychiatry. 49: 53-62. PMID: 24269664
  6. Comparative analysis of pharmacological properties of xanomeline and N-desmethylclozapine in rat brain membranes.  |  Odagaki, Y., et al. 2016. J Psychopharmacol. 30: 896-912. PMID: 27464743
  7. A novel muscarinic receptor-independent mechanism of KCNQ2/3 potassium channel blockade by Oxotremorine-M.  |  Zwart, R., et al. 2016. Eur J Pharmacol. 791: 221-228. PMID: 27590358
  8. STEP activation by Gαq coupled GPCRs opposes Src regulation of NMDA receptors containing the GluN2A subunit.  |  Tian, M., et al. 2016. Sci Rep. 6: 36684. PMID: 27857196
  9. Oxotremorine-M potentiates NMDA receptors by muscarinic receptor dependent and independent mechanisms.  |  Zwart, R., et al. 2018. Biochem Biophys Res Commun. 495: 481-486. PMID: 29127015
  10. TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.  |  Kurimoto, E., et al. 2019. PLoS One. 14: e0207969. PMID: 30856192
  11. Role of Kv7.2/Kv7.3 and M1 muscarinic receptors in the regulation of neuronal excitability in hiPSC-derived neurons.  |  Kreir, M., et al. 2019. Eur J Pharmacol. 858: 172474. PMID: 31238068
  12. In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M1 Receptor, and Xanomeline, an Agonist of Muscarinic M1/M4 Receptor, in Rodents.  |  Mandai, T., et al. 2019. Neuroscience. 414: 60-76. PMID: 31299348
  13. Biased Profile of Xanomeline at the Recombinant Human M4 Muscarinic Acetylcholine Receptor.  |  McDonald, JK., et al. 2022. ACS Chem Neurosci. 13: 1206-1218. PMID: 35380782
  14. Click Chemistry-Enabled Conjugation Strategy for Producing Dibenzodiazepinone-Type Fluorescent Probes To Target M2 Acetylcholine Receptors.  |  Yang, H., et al. 2022. Bioconjug Chem. 33: 2223-2233. PMID: 36327428

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Xanomeline oxalate, 10 mg

sc-204402
10 mg
$155.00